首页> 外国专利> Corticoid - 17, 21 - Esters of dicarboxylic acids, as well as corticoid Esters of carboxylic acids - 17 - 21 - Carbonic acid ester.Processes for their Preparation and Pharmaceutical drugs containing I -

Corticoid - 17, 21 - Esters of dicarboxylic acids, as well as corticoid Esters of carboxylic acids - 17 - 21 - Carbonic acid ester.Processes for their Preparation and Pharmaceutical drugs containing I -

机译:皮质类固醇-17,21-二羧酸酯,以及皮质类固醇酯-17-21碳酸酯。其制备方法和含I-的药物

摘要

Corticoid 1721 - Acid Esters as corticoid Esters dicarboxi - 17 - Acid Esters xilicos Carbo - 21 - Carbonic acid ester of formula I in Figure 1: means Choh and CHCI available esteriArbitrary AC, CH, c = o Double Bond (9, 11) and mean Hydrogen, Chlorine, Fluorine, hydrogen fluoride, Methyl means Z, R (1) means eventually substituted aryl or condensate, hetearilo,Being saturated or unsaturated alkyl, a is - rias Times branched with other alkyl groups substituted heteroatoms, inserted with 0, S, N, N is zero or 1,M means Zero or 1 R (2) means (C1 C8 alkyl branched or linear) Figure 2 R (3) means HydrogenMethyl Alpha or beta - procedure for the preparation of a com - position i according to claim 1, characterized in that a) a compound of formula IIFigure 3 in which R is equal to o (5) and the remaining replacing either have the meanings indicated above,
机译:皮质类固醇1721-酸式酯类为二甲酸酯类酯-17-酸式酯类xilicos碳酸酯-21-图1中的式I碳酸酯表示CHOH和CHCI可用的酯基i任意AC,CH,c = o双键(9,11)平均氢,氯,氟,氟化氢,甲基表示Z,R(1)表示最终取代的芳基或缩合物,杂硬脂基,为饱和或不饱和烷基,a为-rias与其他烷基取代的杂原子分支的时间,插入0, S,N,N为零或1,M表示零或1 R(2)表示(C1 C8烷基支链或直链)图2 R(3)表示氢甲基Alpha或beta-制备位置i的方法2.根据权利要求1的化合物,其特征在于a)其中R等于o(5)的图II的式II化合物,其余的取代基具有上述含义,

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号